Cardiac Xenotransplantation

心脏异种移植

基本信息

项目摘要

Xenotransplantation presents an effective solution to donor organ shortage but vigorous immune response across specie barrier limits its success. The level of current immunosuppression used to prolong xenograft survival is lethal and also impractical for clinical use. Therefore, there is a strong need to develop methods to limit immunosuppression and induce immunological tolerance or accommodation. Recently characterized CD4+CD25+ T regulatory cells (Tregs) offer some hope of inducing donor specific immune modulation without much lethality. One of the limitations of their therapeutic use is their presence in very low numbers. In this study we have tried to isolate and expand baboon Tregs and measured their effectiveness in suppressing pig to baboon xenogeneic response. Tregs were isolated from peripheral blood, spleen and lymph nodes of healthy baboons first by CD4+ cells enrichment by magnetic beads and then by sorting CD4+ CD25+ cells via FACS. These sorted cells were tested for their suppressive potential by addition to the co culture of irradiated pig PBMCs and CD4+ CD25- cells. The isolated Tregs were also expanded in culture for 4 weeks in presence of IL2 and irradiated pig PBMCs and were evaluated for their inhibitory effect. Further, flow cytometric assays for intracellular cytokines and surface expression of various activation markers were also performed to study the mechanism of action of these Tregs in this xenotransplant model. The Treg isolation technique was very effective and 97% pure Tregs (1-2% of CD4+ T cells) were isolated. These isolated cells effectively suppressed the vigorous CD4+CD25- cell proliferative response to irradiated pig PBMCs (85 % suppression). These cells also expressed high levels of FoxP3, a potent marker of Tregs. Isolated Tregs expanded 150-200 folds in culture and were also able to suppress CD4+CD25- cells in a similar manner as naove Tregs. Tregs also suppressed the cytokine production by the CD25- cells in response to pig PBMCs, suggesting a possible mechanism of Treg function. With the above experiments it is clear that Tregs are potent suppressors of pig to baboon xenogenic response and they can also be expanded in vitro to achieve sufficient quantity without losing their suppressive potential. Thus, Tregs offer a potential non lethal alternative to non specific immunosuppression currently used to overcome xenograft rejection. In addition to these cellular studies we have commenced performance of pig to baboon orthotopic cardiac xenotransplantation. As a result we are verifying the stability of this animal model and establishing a set of baseline control results from which to compare additional transplants treated with pharmacologic and cell based immunosuppression.
异种器官移植是解决供体器官短缺的有效方法,但强烈的跨种属免疫反应限制了异种器官移植的成功。目前用于延长异种移植物存活的免疫抑制水平是致命的,并且对于临床使用也是不切实际的。因此,迫切需要开发限制免疫抑制和诱导免疫耐受或调节的方法。最近鉴定的CD 4 + CD 25 + T调节细胞(TCRs)提供了诱导供体特异性免疫调节而没有太多致命性的一些希望。其治疗用途的局限性之一是其存在的数量非常低。在这项研究中,我们试图分离和扩大狒狒Tribunal和测量其有效性,抑制猪狒狒异种反应。 从健康狒狒的外周血、脾脏和淋巴结中分离T细胞,首先通过磁珠富集CD 4+细胞,然后通过流式细胞仪分选CD 4 + CD 25+细胞。通过将这些分选的细胞添加到经辐照的猪PBMC和CD 4 + CD 25-细胞的共培养物中来测试它们的抑制潜力。还将分离的T细胞在IL 2和经照射的猪PBMC存在下在培养物中扩增4周,并评价其抑制作用。此外,还进行了细胞内细胞因子和各种活化标志物的表面表达的流式细胞术测定,以研究这些T细胞因子在该异种移植模型中的作用机制。 Treg分离技术是非常有效的,并且分离了97%纯的Treg(1-2%的CD 4 + T细胞)。这些分离的细胞有效地抑制了对辐照的猪PBMC的强烈的CD 4 + CD 25-细胞增殖反应(85%抑制)。 这些细胞还表达高水平的FoxP 3,这是一种有效的TGFAP标志物。分离的TcB在培养物中扩增150-200倍,并且还能够以与未分离的TcB类似的方式抑制CD 4 + CD 25-细胞。TdR还抑制CD 25-细胞响应于猪PBMC的细胞因子产生,表明Treg功能的可能机制。 通过上述实验,清楚的是,Tactobacillus是猪对狒狒异种反应的有效抑制剂,并且它们也可以在体外扩增以达到足够的量而不失去其抑制潜力。因此,TdR为目前用于克服异种移植排斥的非特异性免疫抑制提供了潜在的非致死性替代方案。 除了这些细胞研究,我们已经开始进行猪到狒狒原位异种心脏移植。 因此,我们正在验证该动物模型的稳定性,并建立一组基线对照结果,以比较使用药理学和基于细胞的免疫抑制治疗的其他移植物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Keith A Horvath其他文献

Keith A Horvath的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Keith A Horvath', 18)}}的其他基金

Laser Induced Myocardial Angiogenesis
激光诱导心肌血管生成
  • 批准号:
    6537812
  • 财政年份:
    2001
  • 资助金额:
    $ 69.83万
  • 项目类别:
Laser Induced Myocardial Angiogenesis
激光诱导心肌血管生成
  • 批准号:
    6749558
  • 财政年份:
    2001
  • 资助金额:
    $ 69.83万
  • 项目类别:
Laser Induced Myocardial Angiogenesis
激光诱导心肌血管生成
  • 批准号:
    6370794
  • 财政年份:
    2001
  • 资助金额:
    $ 69.83万
  • 项目类别:
Laser Induced Myocardial Angiogenesis
激光诱导心肌血管生成
  • 批准号:
    6638647
  • 财政年份:
    2001
  • 资助金额:
    $ 69.83万
  • 项目类别:
Myocardial Cellular Stimulation of Angiogenesis
血管生成的心肌细胞刺激
  • 批准号:
    7321782
  • 财政年份:
  • 资助金额:
    $ 69.83万
  • 项目类别:
Cardiac Xenotransplantation
心脏异种移植
  • 批准号:
    7735009
  • 财政年份:
  • 资助金额:
    $ 69.83万
  • 项目类别:
Myocardial Cellular Stimulation of Angiogenesis
血管生成的心肌细胞刺激
  • 批准号:
    7735008
  • 财政年份:
  • 资助金额:
    $ 69.83万
  • 项目类别:
Myocardial Cellular Stimulation of Angiogenesis
血管生成的心肌细胞刺激
  • 批准号:
    7594428
  • 财政年份:
  • 资助金额:
    $ 69.83万
  • 项目类别:
MRI Guided Robotic Cardiac Surgery
MRI 引导机器人心脏手术
  • 批准号:
    7735010
  • 财政年份:
  • 资助金额:
    $ 69.83万
  • 项目类别:
Cardiac Xenotransplantation
心脏异种移植
  • 批准号:
    7321783
  • 财政年份:
  • 资助金额:
    $ 69.83万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 69.83万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了